NM_000814.6:c.241-51488T>C

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The NM_000814.6(GABRB3):​c.241-51488T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.123 in 152,216 control chromosomes in the GnomAD database, including 1,215 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.12 ( 1215 hom., cov: 32)

Consequence

GABRB3
NM_000814.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.998

Publications

5 publications found
Variant links:
Genes affected
GABRB3 (HGNC:4083): (gamma-aminobutyric acid type A receptor subunit beta3) This gene encodes a member of the ligand-gated ionic channel family. The encoded protein is one the subunits of a multi-subunit chloride channel that serves as the receptor for gamma-aminobutyric acid, a major inhibitory neurotransmitter of the mammalian nervous system. This gene is located on the long arm of chromosome 15 in a cluster with two other genes encoding related subunits of the family. This gene may be associated with the pathogenesis of several disorders including Angelman syndrome, Prader-Willi syndrome, nonsyndromic orofacial clefts, epilepsy and autism. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2013]
GABRB3 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 43
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • epilepsy, childhood absence, susceptibility to, 5
    Inheritance: AD, Unknown Classification: DEFINITIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.145 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GABRB3NM_000814.6 linkc.241-51488T>C intron_variant Intron 3 of 8 ENST00000311550.10 NP_000805.1 P28472-1
GABRB3NM_021912.5 linkc.241-51488T>C intron_variant Intron 3 of 8 NP_068712.1 P28472-2B2RCW8X5DQY4
GABRB3NM_001191320.2 linkc.-16+43592T>C intron_variant Intron 1 of 6 NP_001178249.1 P28472-4
GABRB3NM_001278631.2 linkc.-111-30494T>C intron_variant Intron 3 of 9 NP_001265560.1 P28472-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GABRB3ENST00000311550.10 linkc.241-51488T>C intron_variant Intron 3 of 8 1 NM_000814.6 ENSP00000308725.5 P28472-1

Frequencies

GnomAD3 genomes
AF:
0.123
AC:
18653
AN:
152098
Hom.:
1216
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.148
Gnomad AMI
AF:
0.161
Gnomad AMR
AF:
0.0840
Gnomad ASJ
AF:
0.0516
Gnomad EAS
AF:
0.0505
Gnomad SAS
AF:
0.0975
Gnomad FIN
AF:
0.158
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.121
Gnomad OTH
AF:
0.115
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.123
AC:
18664
AN:
152216
Hom.:
1215
Cov.:
32
AF XY:
0.121
AC XY:
9010
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.148
AC:
6154
AN:
41526
American (AMR)
AF:
0.0836
AC:
1280
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0516
AC:
179
AN:
3470
East Asian (EAS)
AF:
0.0507
AC:
262
AN:
5172
South Asian (SAS)
AF:
0.0978
AC:
472
AN:
4826
European-Finnish (FIN)
AF:
0.158
AC:
1676
AN:
10598
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.121
AC:
8220
AN:
68002
Other (OTH)
AF:
0.115
AC:
243
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
820
1641
2461
3282
4102
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
220
440
660
880
1100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.117
Hom.:
1766
Bravo
AF:
0.119

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
8.2
DANN
Benign
0.84
PhyloP100
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1863455; hg19: chr15-26918169; API